These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
429 related articles for article (PubMed ID: 26189695)
1. Interleukin-6: Biology, signaling and strategies of blockade. Schaper F; Rose-John S Cytokine Growth Factor Rev; 2015 Oct; 26(5):475-87. PubMed ID: 26189695 [TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 and its receptors: a highly regulated and dynamic system. Wolf J; Rose-John S; Garbers C Cytokine; 2014 Nov; 70(1):11-20. PubMed ID: 24986424 [TBL] [Abstract][Full Text] [Related]
3. Impact of interleukin-6 classic- and trans-signaling on liver damage and regeneration. Drucker C; Gewiese J; Malchow S; Scheller J; Rose-John S J Autoimmun; 2010 Feb; 34(1):29-37. PubMed ID: 19717281 [TBL] [Abstract][Full Text] [Related]
4. The IL-6/gp130/STAT3 signaling axis: recent advances towards specific inhibition. Garbers C; Aparicio-Siegmund S; Rose-John S Curr Opin Immunol; 2015 Jun; 34():75-82. PubMed ID: 25749511 [TBL] [Abstract][Full Text] [Related]
5. Local blockade of IL-6R signaling induces lung CD4+ T cell apoptosis in a murine model of asthma via regulatory T cells. Finotto S; Eigenbrod T; Karwot R; Boross I; Doganci A; Ito H; Nishimoto N; Yoshizaki K; Kishimoto T; Rose-John S; Galle PR; Neurath MF Int Immunol; 2007 Jun; 19(6):685-93. PubMed ID: 17496315 [TBL] [Abstract][Full Text] [Related]
6. IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6. Rose-John S Int J Biol Sci; 2012; 8(9):1237-47. PubMed ID: 23136552 [TBL] [Abstract][Full Text] [Related]
7. Interleukin-6: A Masterplayer in the Cytokine Network. Uciechowski P; Dempke WCM Oncology; 2020; 98(3):131-137. PubMed ID: 31958792 [TBL] [Abstract][Full Text] [Related]
8. Effects of blockade of peripheral interleukin-6 trans-signaling on hippocampus-dependent and independent memory in mice. Braun O; Dewitz C; Möller-Hackbarth K; Scheller J; Schiffelholz T; Baier PC; Rose-John S J Interferon Cytokine Res; 2013 May; 33(5):254-60. PubMed ID: 23215755 [TBL] [Abstract][Full Text] [Related]
9. Hitting a complex target: an update on interleukin-6 trans-signalling. Waetzig GH; Rose-John S Expert Opin Ther Targets; 2012 Feb; 16(2):225-36. PubMed ID: 22324903 [TBL] [Abstract][Full Text] [Related]
10. The soluble Interleukin 6 receptor: generation and role in inflammation and cancer. Chalaris A; Garbers C; Rabe B; Rose-John S; Scheller J Eur J Cell Biol; 2011; 90(6-7):484-94. PubMed ID: 21145125 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer. Rose-John S; Scheller J; Elson G; Jones SA J Leukoc Biol; 2006 Aug; 80(2):227-36. PubMed ID: 16707558 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling. Jones SA; Scheller J; Rose-John S J Clin Invest; 2011 Sep; 121(9):3375-83. PubMed ID: 21881215 [TBL] [Abstract][Full Text] [Related]
13. IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer. Neurath MF; Finotto S Cytokine Growth Factor Rev; 2011 Apr; 22(2):83-9. PubMed ID: 21377916 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic blockade of the interleukin-6 receptor (IL-6R) allows sIL-6R generation by proteolytic cleavage. Prenissl N; Lokau J; Rose-John S; Haybaeck J; Garbers C Cytokine; 2019 Feb; 114():1-5. PubMed ID: 30557809 [TBL] [Abstract][Full Text] [Related]
15. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo. Atreya R; Mudter J; Finotto S; Müllberg J; Jostock T; Wirtz S; Schütz M; Bartsch B; Holtmann M; Becker C; Strand D; Czaja J; Schlaak JF; Lehr HA; Autschbach F; Schürmann G; Nishimoto N; Yoshizaki K; Ito H; Kishimoto T; Galle PR; Rose-John S; Neurath MF Nat Med; 2000 May; 6(5):583-8. PubMed ID: 10802717 [TBL] [Abstract][Full Text] [Related]
16. [Interleukin-6 From molecular mechanisms of signal transduction to physiological properties and therapeutic targeting]. Drutskaya MS; Nosenko MA; Atretkhany KS; Efimov GA; Nedospasov SA Mol Biol (Mosk); 2015; 49(6):937-43. PubMed ID: 26710772 [TBL] [Abstract][Full Text] [Related]
17. The role of IL-6 trans-signaling in vascular leakage: implications for ovarian hyperstimulation syndrome in a murine model. Wei LH; Chou CH; Chen MW; Rose-John S; Kuo ML; Chen SU; Yang YS J Clin Endocrinol Metab; 2013 Mar; 98(3):E472-84. PubMed ID: 23348396 [TBL] [Abstract][Full Text] [Related]
18. IL-6/IL-6 receptor system and its role in physiological and pathological conditions. Mihara M; Hashizume M; Yoshida H; Suzuki M; Shiina M Clin Sci (Lond); 2012 Feb; 122(4):143-59. PubMed ID: 22029668 [TBL] [Abstract][Full Text] [Related]
19. Role of the IL-6 classic- and trans-signaling pathways in corneal sterile inflammation and wound healing. Ebihara N; Matsuda A; Nakamura S; Matsuda H; Murakami A Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):8549-57. PubMed ID: 21989726 [TBL] [Abstract][Full Text] [Related]
20. Distinct Effects of IL-6 Classic and Trans-Signaling in Bone Fracture Healing. Prystaz K; Kaiser K; Kovtun A; Haffner-Luntzer M; Fischer V; Rapp AE; Liedert A; Strauss G; Waetzig GH; Rose-John S; Ignatius A Am J Pathol; 2018 Feb; 188(2):474-490. PubMed ID: 29146294 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]